MFDS
- Status: likely_approved
🇰🇷 Viramune in South Korea
Viramune (NEVIRAPINE) regulatory status in South Korea.
Marketing authorisation
Viramune in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Viramune approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Viramune in South Korea?
Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.